JOHNSON & JOHNSON — Director's Dealing 2012

Oct 5, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2012-10-01

Reporting Person: Stoffels Paulus (Chief Scientific Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	98	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$66.18	2015-02-13	Common Stock (24000)		Direct
Stock Option (Right to Buy)	$65.62	2017-02-10	Common Stock (29168)		Direct
Stock Option (Right to Buy)	$61.75	2018-02-10	Common Stock (19109)		Direct
Stock Option (Right to Buy)	$62.62	2020-02-07	Common Stock (24521)		Direct
Stock Option (Right to Buy)	$62.20	2021-01-08	Common Stock (24920)		Direct
Stock Option (Right to Buy)	$65.37	2022-01-14	Common Stock (160133)		Direct
Restricted Share Units	$		Common Stock (18391)		Direct
Restricted Share Units	$		Common Stock (18690)		Direct
Restricted Share Units	$		Common Stock (11629)		Direct
Performance Share Units	$0		Common Stock (29073)		Direct

Footnotes

F1: Belgian grant vested and exercisable on January 1st of the year following the third anniversary of the date of grant.

F2: Vested and exercisable one day after the third anniversary of the date of grant.

F3: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

F4: Each Performance Share Unit converts into one share of Common Stock upon distribution in the first quarter of 2015 based on a performance factor.